Back to top
more

Portage Biotech (PRTG)

(Delayed Data from NSDQ)

$0.27 USD

0.27
123,840

+0.01 (4.27%)

Updated May 3, 2024 03:59 PM ET

After-Market: $0.27 0.00 (-0.37%) 7:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for Portage Biotech Inc falls in the month of March.

All items in Millions except Per Share data.

3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Assets          
Cash & Equivalents -99,999 11 23 3 3
Receivables NA 0 0 0 0
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 3 1 2 1
Total Current Assets NA 14 25 5 4
Net Property & Equipment NA 82 117 117 117
Investments & Advances NA 3 9 9 9
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 43 43 43
Deposits & Other Assets NA 1 0 0 0
Total Assets NA 99 195 175 173
Liabilities & Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Notes Payable NA 0 0 0 0
Accounts Payable NA 2 1 2 1
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 1 1
Total Current Liabilities NA 2 1 3 3
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 11 28 24 22
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 11 0 0 3
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 24 29 27 28
Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 219 158 131 118
Capital Surplus NA 0 0 0 0
Retained Earnings NA -160 -55 -38 -22
Other Equity NA 16 62 55 50
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 75 165 148 146
Total Liabilities & Shareholder's Equity NA 99 195 175 173
Total Common Equity 0 75 165 148 146
Shares Outstanding 17.80 16.90 13.30 12.00 NA
Book Value Per Share 0.00 4.46 12.44 12.30 0.00

Fiscal Year End for Portage Biotech Inc falls in the month of March.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 5 3 8 11
Receivables NA 0 0 0 0
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 2 2 3 3
Total Current Assets NA 8 6 11 14
Net Property & Equipment NA 35 82 82 82
Investments & Advances NA 6 3 5 3
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 1 1 1 1
Total Assets NA 49 92 98 99
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 3 3 3 2
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 3 3 3 2
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 10 10 11
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 13 12 11
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 18 25 26 24
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 219 219 219 219
Capital Surplus NA 0 0 0 0
Retained Earnings NA -210 -171 -166 -160
Other Equity NA 22 18 19 16
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 31 67 73 75
Total Liabilities & Shareholder's Equity NA 49 92 98 99
Total Common Equity 0 31 67 73 75
Shares Outstanding 17.80 17.80 17.80 16.90 16.90
Book Value Per Share 0.00 1.76 3.76 4.30 4.46